World Health Organization site
Skip Navigation Links

Main
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: Netherlands Trial Register
Last refreshed on: 28 April 2013
Main ID:  NTR834
Date of registration: 11/12/2006
Primary sponsor: University Hospital Maastricht (AZM), Department of Ophthalmology
Public title: More efficient use of corneal donations: the Dutch Lamellar Corneal Transplantation Study.
Scientific title: More efficient use of corneal donations: the Dutch Lamellar Corneal Transplantation Study. - DLCTS-study
Date of first enrolment: 1/1/2005
Target sample size: 140
Recruitment status: recruiting
URL:  http://www.trialregister.nl/trialreg/admin/rctview.asp?TC=834
Study type:  intervention
Study design:  Randomised: Yes; Masking: None; Control: Active; Group: Parallel; Type: -  
Countries of recruitment
The Netherlands
Contacts
Name: Rudy M.M.A.  Nuijts
Address:  University Eye Clinic Maastricht P.O. Box 5800, P. Debyelaan 25 6202 AZ Maastricht The Netherlands
Telephone: +31 (0)43 3877344
Email: rudy.nuijts@mumc.nl
Affiliation: 
Name: Rudy M.M.A.  Nuijts
Address:  University Eye Clinic Maastricht P.O. Box 5800, P. Debyelaan 25 6202 AZ Maastricht The Netherlands
Telephone: +31 (0)43 3877344
Email: rudy.nuijts@mumc.nl
Affiliation: 
Key inclusion & exclusion criteria
Inclusion criteria: Deep Anterior Lamellar Keratoplasty:
1. Keratoconus intolerant for contact lens wear, without previous hydrops or Descemet?s rupture;
2. Stromal opacification not reaching Descemet?s membrane and without concomitant endothelial disease;
3. Best Spectacle Corrected Visual Acuity (BSCVA) < 0.4;
4. Patients who signed the informed consent.

Exclusion criteria: Posterior Lamellar Keratoplasty:
1. Endothelial dysfunction caused by pseudophakic or aphakic corneal edema;
2. (Fuchs?) Endothelial dystrophy;
3. BSCVA < 0.4;
4. Without severe scarring of the anterior stromal cornea;
5. Patients who signed the informed consent.


Age minimum:
Age maximum:
Gender:
Health Condition(s) or Problem(s) studied
Corneal disorders

Intervention(s)
Group 1:
Deep Anterior Lamellar Keratoplasty compared to Penetrating Keratoplasty.

Group 2:
Posterior Lamellar Keratoplasty compared to Penetrating Keratoplasty.
Primary Outcome(s)
Discard rate of donated corneas.
Secondary Outcome(s)
Visual acuity, astigmatism, stray light evaluation, contrast sensitivity, endothelial cell loss, incidence endothelial rejection, vision-related quality of life and patient satisfaction. Before operation, and at 3, 6, 12 months after operation.
A full economic evaluation.
Secondary ID(s)
ISRCTN02191620
ZonMw-945-04-454
Source(s) of Monetary Support
ZON-MW, The Netherlands Organization for Health Research and Development, Netherlands Society for the Prevention of Blindness, Dutch Association of the Blind and Partially Sighted
Secondary Sponsor(s)
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.1 - Version history